From: The TERT rs2736100 Polymorphism and Cancer Risk: A Meta-analysis Based on 25 Case-Control Studies
ID | First author | Year | Ethnicity | Cancer type | Source of controls | Total | Cases | Controls | HWE | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  |  | TT | TG | GG | TT | TG | GG |  |
1 | Jin(China)[21] | 2009 | Asian | Lung cancer | PB | 2551 | 353 | 627 | 232 | 450 | 658 | 231 | 0.72 |
2 | Wang(England) [22] | 2010 | European | Lung cancer | PB | 792 | 42 | 115 | 82 | 136 | 259 | 158 | 0.15 |
3 | Kohno(Japan) [23] | 2010 | Asian | Lung cancer | MIXED | 2624 | 488 | 796 | 372 | 373 | 460 | 135 | 0.72 |
4 | Hsiung(China-GELAC) [24] | 2010 | Asian | Lung cancer | PB | 1169 | 118 | 330 | 136 | 225 | 278 | 82 | 0.79 |
5 | Hsiung(China-GELAC(replication)) [24] | 2010 | Asian | Lung cancer | PB | 1170 | 156 | 318 | 136 | 214 | 260 | 86 | 0.63 |
6 | Hsiung(China-CAMSCH) [24] | 2010 | Asian | Lung cancer | PB | 556 | 71 | 122 | 77 | 87 | 154 | 45 | 0.09 |
7 | Hsiung(Korea-SNU) [24] | 2010 | Asian | Lung cancer | PB | 542 | 87 | 125 | 44 | 114 | 141 | 31 | 0.19 |
8 | Hsiung(Korea-KNUH) [24] | 2010 | Asian | Lung cancer | PB | 227 | 40 | 52 | 26 | 44 | 46 | 19 | 0.25 |
9 | Hsiung(Korea-KUMC) [24] | 2010 | Asian | Lung cancer | PB | 176 | 31 | 47 | 15 | 31 | 41 | 11 | 0.66 |
10 | Hsiung(China-WHLCS) [24] | 2010 | Asian | Lung cancer | HB | 381 | 50 | 83 | 42 | 65 | 104 | 37 | 0.68 |
11 | MiKi(Japan) [25] | 2010 | Asian | Lung cancer | MIXED | 2904 | 291 | 498 | 215 | 696 | 890 | 314 | 0.30 |
12 | MiKi(Japan(replication)) [25] | 2010 | Asian | Lung cancer | HB | 8201 | 157 | 273 | 95 | 2830 | 3664 | 1182 | 0.94 |
13 | MiKi(Korea) [25] | 2010 | Asian | Lung cancer | HB | 2015 | 174 | 277 | 106 | 567 | 692 | 199 | 0.60 |
14 | Hu(China) [26] | 2011 | Asian | Lung cancer | HB | 17937 | 2393 | 4294 | 1872 | 3231 | 4533 | 1614 | 0.72 |
15 | Shete(England) [27] | 2009 | European | Glioma | PB | 2065 | 115 | 316 | 200 | 349 | 676 | 409 | 0.04 |
16 | Shete(America) [27] | 2009 | European | Glioma | HB | 3480 | 230 | 645 | 372 | 546 | 1103 | 584 | 0.58 |
17 | Shete(France) [27] | 2009 | European | Glioma | PB | 2913 | 225 | 686 | 441 | 383 | 807 | 371 | 0.18 |
18 | Shete(German) [27] | 2009 | European | Glioma | PB | 1056 | 91 | 240 | 160 | 133 | 269 | 163 | 0.28 |
19 | Shete(Sweden) [27] | 2009 | European | Glioma | PB | 1387 | 120 | 326 | 177 | 212 | 367 | 185 | 0.29 |
20 | Wrensch(America) [28] | 2009 | European | Glioma | PB | 4672 | 95 | 354 | 242 | 1021 | 1904 | 1056 | 0.01 |
21 | Schoemaker(Denmark) [29] | 2010 | European | Glioma | PB | 265 | 22 | 58 | 39 | 31 | 74 | 41 | 0.82 |
22 | Schoemaker(Finland) [29] | 2010 | European | Glioma | PB | 192 | 8 | 56 | 33 | 23 | 53 | 19 | 0.25 |
23 | Chen(China) [30] | 2011 | Asian | Glioma | HB | 1989 | 244 | 515 | 194 | 334 | 542 | 160 | 0.01 |
24 | Gago-Dominguez(America) [31] | 2010 | European | Bladder cancer | PB | 1018 | 86 | 239 | 146 | 127 | 262 | 158 | 0.36 |
25 | Gago-Dominguez(China) [31] | 2010 | Asian | Bladder cancer | PB | 1024 | 141 | 260 | 98 | 174 | 274 | 77 | 0.06 |